{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T10:44:55Z","timestamp":1780569895253,"version":"3.54.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Open Project of Key Laboratory of Dermatology(Anhui Medical University), Ministry of Education","award":["AYPY2024-10"],"award-info":[{"award-number":["AYPY2024-10"]}]},{"name":"Open Project of Key Laboratory of Dermatology(Anhui Medical University), Ministry of Education","award":["AYPY2024-10"],"award-info":[{"award-number":["AYPY2024-10"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Dermatol Res"],"DOI":"10.1007\/s00403-025-03836-5","type":"journal-article","created":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T07:58:44Z","timestamp":1738396724000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Sj\u00f6gren\u2019s syndrome and psoriasis: a two-sample Mendelian randomization study"],"prefix":"10.1007","volume":"317","author":[{"given":"Bingqing","family":"Dai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Xin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wang","family":"Jun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,1]]},"reference":[{"issue":"9997","key":"3836_CR1","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1016\/S0140-6736(14)61909-7","volume":"386","author":"WH Boehncke","year":"2015","unstructured":"Boehncke WH, Sch\u00f6n MP (2015) Psoriasis. The Lancet 386(9997):983\u2013994. https:\/\/doi.org\/10.1016\/S0140-6736(14)61909-7","journal-title":"The Lancet"},{"issue":"5","key":"3836_CR2","doi-asserted-by":"publisher","first-page":"e63619","DOI":"10.1371\/journal.pone.0063619","volume":"8","author":"D H\u00e4gg","year":"2013","unstructured":"H\u00e4gg D, Eriksson M, Sundstr\u00f6m A, Schmitt-Egenolf M (2013) The higher proportion of men with psoriasis treated with biologics may be explained by more severe disease in Men. PLoS\u00a0One 8(5):e63619. https:\/\/doi.org\/10.1371\/journal.pone.0063619","journal-title":"PLoS\u00a0One"},{"issue":"19","key":"3836_CR3","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1001\/jama.2020.4006","volume":"323","author":"AW Armstrong","year":"2020","unstructured":"Armstrong AW, Read C (2020) Pathophysiology, clinical presentation, and treatment of psoriasis: a review. JAMA 323(19):1945. https:\/\/doi.org\/10.1001\/jama.2020.4006","journal-title":"JAMA"},{"issue":"suppl_2","key":"3836_CR4","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1136\/ard.2004.033217","volume":"64","author":"RGB Langley","year":"2005","unstructured":"Langley RGB (2005) Psoriasis: epidemiology, clinical features, and quality of life. Ann Rheumatic Dis 64(suppl_2):18\u201323. https:\/\/doi.org\/10.1136\/ard.2004.033217","journal-title":"Ann Rheumatic Dis"},{"issue":"5","key":"3836_CR5","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1001\/archderm.1981.01650050005005","volume":"117","author":"PRJ Burch","year":"1981","unstructured":"Burch PRJ, Rowell NR (1981) Mode of inheritance in psoriasis. Arch Dermatol 117(5):251. https:\/\/doi.org\/10.1001\/archderm.1981.01650050005005","journal-title":"Arch Dermatol"},{"issue":"3","key":"3836_CR6","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1159\/000247341","volume":"186","author":"AE Smith","year":"1993","unstructured":"Smith AE, Kassab JY, Payne R, Beer WE (1993) Bimodality in age of onset of psoriasis, both patients and their relatives. Dermatology 186(3):181\u2013186. https:\/\/doi.org\/10.1159\/000247341","journal-title":"Dermatology"},{"issue":"6","key":"3836_CR7","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1067\/mjd.2002.120470","volume":"46","author":"C Ferr\u00e1ndiz","year":"2002","unstructured":"Ferr\u00e1ndiz C, Pujol RM, Garc\u00eda-Patos V, Bordas X, Smand\u00eda JA (2002) Psoriasis of early and late onset: a clinical and epidemiologic study from Spain. J Am Acad Dermatol 46(6):867\u2013873. https:\/\/doi.org\/10.1067\/mjd.2002.120470","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"3836_CR8","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/S0190-9622(85)70188-0","volume":"13","author":"T Henseler","year":"1985","unstructured":"Henseler T, Christophers E (1985) Psoriasis of early and late onset: characterization of two types of psoriasis vulgaris. J Am Acad Dermatol 13(3):450\u2013456. https:\/\/doi.org\/10.1016\/S0190-9622(85)70188-0","journal-title":"J Am Acad Dermatol"},{"issue":"8","key":"3836_CR9","doi-asserted-by":"publisher","first-page":"438","DOI":"10.12968\/hmed.2017.78.8.438","volume":"78","author":"I Thorne","year":"2017","unstructured":"Thorne I, Sutcliffe N (2017) Sj\u00f6gren\u2019s syndrome. Br J Hosp Med (Lond) 78(8):438\u2013442. https:\/\/doi.org\/10.12968\/hmed.2017.78.8.438","journal-title":"Br J Hosp Med (Lond)"},{"issue":"1","key":"3836_CR10","doi-asserted-by":"publisher","first-page":"16047","DOI":"10.1038\/nrdp.2016.47","volume":"2","author":"P Brito-Zer\u00f3n","year":"2016","unstructured":"Brito-Zer\u00f3n P, Baldini C, Bootsma H et al (2016) Sj\u00f6gren syndrome. Nat Rev Dis Primers 2(1):16047. https:\/\/doi.org\/10.1038\/nrdp.2016.47","journal-title":"Nat Rev Dis Primers"},{"issue":"2","key":"3836_CR11","doi-asserted-by":"publisher","first-page":"135","DOI":"10.3109\/03009742.2014.931457","volume":"44","author":"M Kvarnstr\u00f6m","year":"2015","unstructured":"Kvarnstr\u00f6m M, Ottosson V, Nordmark B, Wahren-Herlenius M (2015) Incident cases of primary Sj\u00f6gren\u2019s syndrome during a 5-year period in Stockholm County: a descriptive study of the patients and their characteristics. Scand J Rheumatol 44(2):135\u2013142. https:\/\/doi.org\/10.3109\/03009742.2014.931457","journal-title":"Scand J Rheumatol"},{"issue":"4","key":"3836_CR12","doi-asserted-by":"publisher","first-page":"706","DOI":"10.3899\/jrheum.100883","volume":"38","author":"MY Weng","year":"2011","unstructured":"Weng MY, Huang YT, Liu MF, Lu TH (2011) Incidence and mortality of treated primary Sj\u00f6gren\u2019s syndrome in Taiwan: a population-based study. J Rheumatol 38(4):706\u2013708. https:\/\/doi.org\/10.3899\/jrheum.100883","journal-title":"J Rheumatol"},{"issue":"3","key":"3836_CR13","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1002\/acr.22115","volume":"66","author":"C Maldini","year":"2014","unstructured":"Maldini C, Seror R, Fain O et al (2014) Epidemiology of primary Sj\u00f6gren\u2019s syndrome in a French multiracial\/multiethnic area. Arthritis Care Res (Hoboken) 66(3):454\u2013463. https:\/\/doi.org\/10.1002\/acr.22115","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"5","key":"3836_CR14","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1080\/03009740600759704","volume":"35","author":"Y Kabasakal","year":"2006","unstructured":"Kabasakal Y, Kitapcioglu G, Turk T et al (2006) The prevalence of Sj\u00f6gren\u2019s syndrome in adult women. Scand J Rheumatol 35(5):379\u2013383. https:\/\/doi.org\/10.1080\/03009740600759704","journal-title":"Scand J Rheumatol"},{"issue":"19","key":"3836_CR15","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1001\/jama.2017.17219","volume":"318","author":"CA Emdin","year":"2017","unstructured":"Emdin CA, Khera AV, Kathiresan S (2017) Mendelian randomization. JAMA 318(19):1925\u20131926. https:\/\/doi.org\/10.1001\/jama.2017.17219","journal-title":"JAMA"},{"issue":"7","key":"3836_CR16","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1002\/gepi.21758","volume":"37","author":"S Burgess","year":"2013","unstructured":"Burgess S, Butterworth A, Thompson SG (2013) Mendelian randomization analysis with multiple genetic variants using summarized data. Genet Epidemiol 37(7):658\u2013665. https:\/\/doi.org\/10.1002\/gepi.21758","journal-title":"Genet Epidemiol"},{"issue":"6","key":"3836_CR17","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.1093\/ije\/dyw220","volume":"45","author":"J Bowden","year":"2016","unstructured":"Bowden J, Del Greco MF, Minelli C, Davey Smith G, Sheehan NA, Thompson JR (2016) Assessing the suitability of summary data for two-sample Mendelian randomization analyses using MR-Egger regression: the role of the I2 statistic. Int J Epidemiol 45(6):1961\u20131974. https:\/\/doi.org\/10.1093\/ije\/dyw220","journal-title":"Int J Epidemiol"},{"issue":"4","key":"3836_CR18","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1002\/gepi.21965","volume":"40","author":"J Bowden","year":"2016","unstructured":"Bowden J, Davey Smith G, Haycock PC, Burgess S (2016) Consistent estimation in Mendelian randomization with some invalid instruments using a weighted median estimator. Genet Epidemiol 40(4):304\u2013314. https:\/\/doi.org\/10.1002\/gepi.21965","journal-title":"Genet Epidemiol"},{"issue":"11","key":"3836_CR19","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1002\/sim.7221","volume":"36","author":"J Bowden","year":"2017","unstructured":"Bowden J, Del Greco MF, Minelli C, Davey Smith G, Sheehan N, Thompson J (2017) A framework for the investigation of pleiotropy in two-sample summary data Mendelian randomization. Stat Med 36(11):1783\u20131802. https:\/\/doi.org\/10.1002\/sim.7221","journal-title":"Stat Med"},{"issue":"5","key":"3836_CR20","doi-asserted-by":"publisher","first-page":"688","DOI":"10.25259\/IJDVL_8_2023","volume":"89","author":"SP Raychaudhuri","year":"2023","unstructured":"Raychaudhuri SP, Raychaudhuri SK (2023) JAK inhibitor: introduction. Indian J Dermatol Venereol Leprol 89(5):688\u2013690. https:\/\/doi.org\/10.25259\/IJDVL_8_2023","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"3836_CR21","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1146\/annurev-med-051113-024537","volume":"66","author":"JJ O\u2019Shea","year":"2015","unstructured":"O\u2019Shea JJ, Schwartz DM, Villarino AV, Gadina M, McInnes IB, Laurence A (2015) The JAK-STAT pathway: impact on human disease and therapeutic intervention. Annu Rev Med 66:311\u2013328. https:\/\/doi.org\/10.1146\/annurev-med-051113-024537","journal-title":"Annu Rev Med"},{"issue":"1","key":"3836_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/sj.cr.7290255","volume":"15","author":"SR Singh","year":"2005","unstructured":"Singh SR, Chen X, Hou SX (2005) JAK\/STAT signaling regulates tissue outgrowth and male germline stem cell fate in drosophila. Cell Res 15(1):1\u20135. https:\/\/doi.org\/10.1038\/sj.cr.7290255","journal-title":"Cell Res"},{"key":"3836_CR23","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1146\/annurev.immunol.16.1.293","volume":"16","author":"WJ Leonard","year":"1998","unstructured":"Leonard WJ, O\u2019Shea JJ (1998) Jaks and STATs: biological implications. Annu Rev Immunol 16:293\u2013322. https:\/\/doi.org\/10.1146\/annurev.immunol.16.1.293","journal-title":"Annu Rev Immunol"},{"issue":"1","key":"3836_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/s1074-7613(00)80505-1","volume":"7","author":"JJ O\u2019Shea","year":"1997","unstructured":"O\u2019Shea JJ (1997) Jaks, STATs, cytokine signal transduction, and immunoregulation: are we there yet? Immunity 7(1):1\u201311. https:\/\/doi.org\/10.1016\/s1074-7613(00)80505-1","journal-title":"Immunity"},{"issue":"3","key":"3836_CR25","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/s0168-9525(97)01006-8","volume":"13","author":"XS Hou","year":"1997","unstructured":"Hou XS, Perrimon N (1997) The JAK-STAT pathway in drosophila. Trends Genet 13(3):105\u2013110. https:\/\/doi.org\/10.1016\/s0168-9525(97)01006-8","journal-title":"Trends Genet"},{"issue":"12","key":"3836_CR26","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1038\/s41590-019-0466-2","volume":"20","author":"FJ Barrat","year":"2019","unstructured":"Barrat FJ, Crow MK, Ivashkiv LB (2019) Interferon target-gene expression and epigenomic signatures in health and disease. Nat Immunol 20(12):1574\u20131583. https:\/\/doi.org\/10.1038\/s41590-019-0466-2","journal-title":"Nat Immunol"},{"key":"3836_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2021.114760","volume":"193","author":"HT Tzeng","year":"2021","unstructured":"Tzeng HT, Chyuan IT, Lai JH (2021) Targeting the JAK-STAT pathway in autoimmune diseases and cancers: a focus on molecular mechanisms and therapeutic potential. Biochem Pharmacol 193:114760. https:\/\/doi.org\/10.1016\/j.bcp.2021.114760","journal-title":"Biochem Pharmacol"},{"issue":"3","key":"3836_CR28","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.drup.2010.04.001","volume":"13","author":"SY Lai","year":"2010","unstructured":"Lai SY, Johnson FM (2010) Defining the role of the JAK-STAT pathway in head and neck and thoracic malignancies: implications for future therapeutic approaches. Drug Resist Updat 13(3):67\u201378. https:\/\/doi.org\/10.1016\/j.drup.2010.04.001","journal-title":"Drug Resist Updat"},{"issue":"9865","key":"3836_CR29","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/S0140-6736(12)61424-X","volume":"381","author":"GR Burmester","year":"2013","unstructured":"Burmester GR, Blanco R, Charles-Schoeman C et al (2013) Tofacitinib (CP-690,550) in combination with methotrexate in patients with active rheumatoid arthritis with an inadequate response to tumour necrosis factor inhibitors: a randomised phase 3 trial. Lancet 381(9865):451\u2013460. https:\/\/doi.org\/10.1016\/S0140-6736(12)61424-X","journal-title":"Lancet"},{"issue":"2","key":"3836_CR30","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1006\/clin.1994.1123","volume":"72","author":"HM Moutsopoulos","year":"1994","unstructured":"Moutsopoulos HM (1994) Sj\u00f6gren\u2019s syndrome: autoimmune epithelitis. Clin Immunol Immunopathol 72(2):162\u2013165. https:\/\/doi.org\/10.1006\/clin.1994.1123","journal-title":"Clin Immunol Immunopathol"},{"issue":"5","key":"3836_CR31","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1191\/0961203306lu2290rr","volume":"15","author":"DI Mitsias","year":"2006","unstructured":"Mitsias DI, Kapsogeorgou EK, Moutsopoulos HM (2006) The role of epithelial cells in the initiation and perpetuation of autoimmune lesions: lessons from Sjogren\u2019s syndrome (autoimmune epithelitis). Lupus 15(5):255\u2013261. https:\/\/doi.org\/10.1191\/0961203306lu2290rr","journal-title":"Lupus"},{"issue":"6","key":"3836_CR32","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/s41584-021-00605-2","volume":"17","author":"GM Verstappen","year":"2021","unstructured":"Verstappen GM, Pringle S, Bootsma H, Kroese FGM (2021) Epithelial-immune cell interplay in primary Sj\u00f6gren syndrome salivary gland pathogenesis. Nat Rev Rheumatol 17(6):333\u2013348. https:\/\/doi.org\/10.1038\/s41584-021-00605-2","journal-title":"Nat Rev Rheumatol"},{"issue":"11","key":"3836_CR33","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1136\/annrheumdis-2019-216588","volume":"79","author":"E Rivi\u00e8re","year":"2020","unstructured":"Rivi\u00e8re E, Pascaud J, Tchitchek N et al (2020) Salivary gland epithelial cells from patients with Sj\u00f6gren\u2019s syndrome induce B-lymphocyte survival and activation. Ann Rheum Dis 79(11):1468\u20131477. https:\/\/doi.org\/10.1136\/annrheumdis-2019-216588","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"3836_CR34","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a028423","volume":"10","author":"H Negishi","year":"2018","unstructured":"Negishi H, Taniguchi T, Yanai H (2018) The interferon (IFN) class of cytokines and the IFN regulatory factor (IRF) transcription factor family. Cold Spring Harb Perspect Biol 10(11):a028423. https:\/\/doi.org\/10.1101\/cshperspect.a028423","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"5","key":"3836_CR35","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1038\/ncprheum0173","volume":"2","author":"G Nordmark","year":"2006","unstructured":"Nordmark G, Alm GV, R\u00f6nnblom L (2006) Mechanisms of disease: primary Sj\u00f6gren\u2019s syndrome and the type I interferon system. Nat Clin Pract Rheumatol 2(5):262\u2013269. https:\/\/doi.org\/10.1038\/ncprheum0173","journal-title":"Nat Clin Pract Rheumatol"},{"issue":"8","key":"3836_CR36","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1038\/ni.2366","volume":"13","author":"DAA Vignali","year":"2012","unstructured":"Vignali DAA, Kuchroo VK (2012) IL-12 family cytokines: immunological playmakers. Nat Immunol 13(8):722\u2013728. https:\/\/doi.org\/10.1038\/ni.2366","journal-title":"Nat Immunol"},{"issue":"2","key":"3836_CR37","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1038\/ng.311","volume":"41","author":"RP Nair","year":"2009","unstructured":"Nair RP, Duffin KC, Helms C et al (2009) Genome-wide scan reveals association of psoriasis with IL-23 and NF-kappaB pathways. Nat Genet 41(2):199\u2013204. https:\/\/doi.org\/10.1038\/ng.311","journal-title":"Nat Genet"},{"issue":"1","key":"3836_CR38","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1084\/jem.20050500","volume":"202","author":"FO Nestle","year":"2005","unstructured":"Nestle FO, Conrad C, Tun-Kyi A et al (2005) Plasmacytoid predendritic cells initiate psoriasis through interferon-alpha production. J Exp Med 202(1):135\u2013143. https:\/\/doi.org\/10.1084\/jem.20050500","journal-title":"J Exp Med"}],"container-title":["Archives of Dermatological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-025-03836-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00403-025-03836-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-025-03836-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T07:58:50Z","timestamp":1738396730000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00403-025-03836-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,1]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3836"],"URL":"https:\/\/doi.org\/10.1007\/s00403-025-03836-5","relation":{},"ISSN":["1432-069X"],"issn-type":[{"value":"1432-069X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,1]]},"assertion":[{"value":"12 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 December 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 January 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 February 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that there are no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"322"}}